Magnetic Resonance in Medical Sciences
Online ISSN : 1880-2206
Print ISSN : 1347-3182
ISSN-L : 1347-3182
Image-based Re-evaluation of the JCOG0911 Study Focusing on Tumor Volume and Survival, Disease Progression Diagnosis, and Radiomic Prognostication for Newly Diagnosed Glioblastoma
Manabu Kinoshita Yasutaka FushimiTomohiko MasumotoKeita SasakiTetsuya SekitaAtsushi NatsumeToshihiko WakabashiTakashi KomoriShunsuke TsuzukiYoshihiro MuragakiKazuya MotomuraRyuta SaitoKenichi SatoTakaaki BeppuMasamichi TakahashiJun-Ichiro KurodaYukihiko SonodaKeiichi KobayashiKazuhiko MishimaKoichi MitsuyaFumiyuki YamasakiAkihiro InoueTomoo MatsutaniHideo NakamuraShigeru YamaguchiEiichi IshikawaMasato NakayaShota TanakaKenta UjifukuHiroyuki UchidaMasayuki KanamoriRyohei OtaniNoriyuki KijimaNamiko NishidaAtsuo YoshinoYohei MineharuYoshiki ArakawaHaruhiko FukudaYoshitaka NaritaMembers of Japan Clinical Oncology Group Brain Tumor Study Group (JCOG-BTSG)
Author information
JOURNAL OPEN ACCESS Advance online publication
Supplementary material

Article ID: mp.2024-0103

Details
Abstract

Purpose: To re-evaluate images recovered from JCOG0911, a randomized phase 2 trial for newly diagnosed glioblastoma (nGBM) conducted by the Japan Clinical Oncology Group (JCOG) Brain Tumor Study Group.

Methods: The correlation between tumor volumes and survival was evaluated, followed by progression-free survival (PFS) analysis by independent central review based on Response Assessment in Neuro-Oncology (RANO) criteria using MRI recovered from 118 nGBM patients enrolled in the JCOG0911 trial. A radiomic analysis was also performed to identify radiomic features predictive of nGBM prognosis.

Results: The distribution of the Gd-enhancing and T2-weighted image/fluid attenuated inversion recovery-high intensity lesions mainly occupied white matter. JCOG0911 consisted of more subjects with right-sided lesions. The median extent of resection of the Gd-enhancing lesions was 99%. The overall survival showed a nonsignificant negative trend with postoperative Gd-enhancing lesion volume (P = 0.22), with the hazard ratio increasing in parallel with its volume. The median PFS after registration was 302 and 308 days for local Response Evaluation Criteria in Solid Tumors (RECIST)-based and central RANO-based diagnoses. However, an apparent discrepancy was observed between the two in the early phase, presumably due to the misdiagnosis of pseudoprogression by local RECIST-based diagnosis. Radiomic analysis identified 28 radiomic features predictive of nGBM prognosis, 5 of which were those previously identified in a separate cohort. The constructed radiomics-based prognostic model stratified the cohort into high- and low-risk groups (P = 0.028).

Conclusion: Novel analytical methods that could be incorporated into future clinical trials were successfully tested. RANO and RECIST may not differ in progression calls if pseudoprogression is appropriately handled.

Content from these authors
© 2024 by Japanese Society for Magnetic Resonance in Medicine

This article is licensed under a Creative Commons [Attribution-NonCommercial-NoDerivatives 4.0 International] license.
https://creativecommons.org/licenses/by-nc-nd/4.0/
Previous article Next article
feedback
Top